The short version
15 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Gabapentin
Gabapentin · GABAPENTIN 50 mg/mL · Solution · Oral · Kesin Pharma Corporation
NDC 81033-0123-44 · 40 CUP, UNIT-DOSE in 1 CARTON / 5 mL in 1 CUP, UNIT-DOSE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$135.00
Reported to Texas DSHS · 2026 annual filing · Kesin Pharma Corporation
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for gabapentin (other) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Kesin Pharma CorporationUnited Stateslabel · pack · repack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA091286
- TE code
- AA
- Approval date
- Mar 14, 2016
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Gabapentin (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Acella Pharmaceuticals, LLC | GABAPENTIN 250 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Advagen Pharma Ltd | GABAPENTIN 250 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Ajenat Pharmaceuticals LLC | GABAPENTIN 250 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| American Health Packaging | GABAPENTIN 250 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals LLC | GABAPENTIN 250 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Atlantic Biologicals Corp. | GABAPENTIN 250 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| BioComp Pharma, Inc. | GABAPENTIN 250 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | GABAPENTIN 250 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | GABAPENTIN 250 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Jvet Pharmaceuticals Llc | GABAPENTIN 250 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Kesin Pharma Corporation | GABAPENTIN 250 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Parke-Davis Div of Pfizer Inc | GABAPENTIN 250 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | GABAPENTIN 250 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Viatris Specialty LLC | GABAPENTIN 250 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Kesin Pharma Corporation | GABAPENTIN 50 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
| PAI Holdings, LLC dba PAI Pharma | GABAPENTIN 250 mg/5mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Gabapentin — NDC 81033-0123-44," retrieved September 3, 2026, https://drugdashboards.com/drug/81033012344.
Free to cite with attribution — see how the data is put together.